Inventory increased 31.2%
Inventory changed +31.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +31.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Capital expenditure changed -75.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Trade receivables changed +21.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -137.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -183.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +410 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +11.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Operating margin changed +962 basis points from the comparable as-filed period.
Operating income changed +29.8% from the comparable as-filed period.
Current ratio changed +20.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
SBC / revenue changed +316 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +27.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +106.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +22.1% from the comparable as-filed period.
Capex / revenue changed -185 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +538 basis points from the comparable as-filed period.
Gross margin changed +161 basis points from the comparable as-filed period.
Gross profit changed +25.2% from the comparable as-filed period.
Debt / assets changed -304 basis points from the comparable as-filed period.
Debt / revenue changed -5963 basis points from the comparable as-filed period.
Net debt changed +20.5% from the comparable as-filed period.
Cost of revenue changed +16.9% from the comparable as-filed period.
Cash / debt changed -449 basis points from the comparable as-filed period.
Free-cash-flow margin changed -1244 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1430 basis points from the comparable as-filed period.
Working capital changed +11.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +6.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed +5.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -5.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed -11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -153 basis points from the comparable as-filed period.
Noncurrent long-term debt changed +2.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -3.8% from the comparable as-filed period.
Receivables / revenue changed -85 basis points from the comparable as-filed period.
Gross debt changed +0.0% from the comparable as-filed period.
Reported total debt changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.